• Applied Immunometabolism with UK-5099: Protocols & Optimizat

  2026-06-09

  Harness the precision of UK-5099 (PF-1005023) to dissect mitochondrial metabolism in immune cells. This guide delivers advanced workflows and troubleshooting tips grounded in recent protocol innovations, empowering reproducible immunometabolic research.

• LEE011 Succinate: Applied CDK Inhibition for Cancer Research

  2026-06-09

  Harness the precision of Ribociclib succinate (LEE011 succinate) as a selective CDK inhibitor to drive robust cell cycle and antineoplastic workflows in cancer research. This guide delivers actionable protocol enhancements, troubleshooting strategies, and integrates the latest biomarker insights to elevate assay reproducibility and data depth.

• Cefotaxime in Bacterial Evolution Studies: Beyond Resistance

  2026-06-08

  Discover how Cefotaxime, a third-generation cephalosporin antibiotic, advances research on bacterial adaptation and gene transfer. This article uniquely explores its role in dissecting evolutionary pressures and horizontal gene transfer in complex infection models.

• LMO2–LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-06-08

  This study uncovers the crucial oncogenic role of the LMO2–LDB1 transcriptional complex in acute myeloid leukemia (AML). By dissecting the molecular mechanisms and experimental perturbations of LMO2 and LDB1, the research highlights new avenues for targeting key protein interactions in AML therapy.

• SIS3 (Smad3 Inhibitor): Mechanistic Insights for Translation

  2026-06-07

  Explore how SIS3, a potent Smad3 inhibitor, enables high-precision modulation of the TGF-β signaling pathway for translational fibrosis and osteoarthritis research. This article uniquely dissects SIS3’s mechanistic impact on molecular assay design and practical experimental outcomes.

• SB 431542: ALK5 Inhibitor for Precision TGF-β Pathway Resear

  2026-06-06

  SB 431542 enables targeted inhibition of ALK5 within the TGF-β pathway, supporting reproducible modulation of cell proliferation, immune response, and fibrosis in both cellular and in vivo studies. This advanced inhibitor, supplied by APExBIO, is indispensable for dissecting Smad2 phosphorylation and anti-tumor immunology with quantifiable rigor.

• Captopril: ACE Inhibitor Benchmarks and Translational Insigh

  2026-06-05

  Captopril is a well-characterized ACE inhibitor with an IC50 of 6 nM, validated for antihypertensive and anticancer research. Its precise mechanism, high purity, and robust solubility profile support reproducible results in cardiovascular and translational oncology workflows.

• Pioglitazone: PPARγ Agonist Workflows for Inflammatory and M

  2026-06-05

  Pioglitazone, a selective PPARγ agonist from APExBIO, enables researchers to dissect insulin resistance, modulate macrophage polarization, and protect against inflammation in complex disease models. This guide translates recent mechanistic breakthroughs into actionable protocols and troubleshooting strategies for metabolic and immune modulation research.

• HDAC6-Driven α-Tubulin Lactylation Links Metabolism to Micro

  2026-06-04

  This study identifies HDAC6 as a principal enzyme catalyzing reversible lactylation of α-tubulin at lysine 40, revealing a novel metabolic regulation of microtubule dynamics. These findings provide new mechanistic insight into how cellular lactate influences cytoskeletal behavior, with implications for neurobiology and cell cycle research.

• Bestatin (Ubenimex): Precision in Aminopeptidase Assays & MD

  2026-06-04

  Bestatin (Ubenimex) delivers unrivaled specificity for dissecting aminopeptidase-mediated pathways, enabling researchers to decode multidrug resistance and apoptosis mechanisms in cancer models. Practical guidance on experimental workflows, troubleshooting, and advanced applications positions this APExBIO reagent as a cornerstone for protease and MDR research.

• Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4

  2026-06-03

  Explore how Morin, a natural flavonoid, uniquely modulates podocyte mitochondrial function through AMPD inhibition. This in-depth article reveals mechanistic insights and practical assay considerations that set Morin apart in diabetes and kidney research.

• UBE2F-SAG–Mediated RHEB Neddylation Drives mTORC1 in Liver C

  2026-06-03

  This study reveals that RHEB is directly neddylated by the UBE2F-SAG axis, a modification that enhances mTORC1 activity and promotes liver tumorigenesis. By delineating this non-cullin substrate pathway, the paper identifies new intervention targets for hepatocellular carcinoma and provides a foundation for mechanistic studies of post-translational modifications.

• Pepstatin A: Applied Aspartic Protease Inhibitor Workflows

  2026-06-02

  Pepstatin A enables precise, reproducible inhibition of aspartic proteases for studies in viral protein processing, osteoclast differentiation, and endothelial dysfunction. This article decodes advanced protocols, troubleshooting, and insights inspired by the latest mechanistic research and APExBIO’s ultra-pure formulation.

• Carvacrol (5-Isopropyl-2-Methylphenol): Advanced Redox Pathw

  2026-06-02

  Explore the multifaceted role of Carvacrol (5-isopropyl-2-methylphenol) in modulating redox signaling, cell cycle arrest, and TRP channel dynamics. This article uniquely bridges mechanistic insights with practical assay guidance for researchers seeking depth beyond standard protocols.

• Rotigotine Hydrochloride: Dopamine D2/D3 Receptor Agonist in

  2026-06-01

  Rotigotine hydrochloride stands out as a versatile dopamine D2/D3 receptor agonist, offering reproducible neuroprotection and robust modeling of Parkinson’s disease and related disorders. This article delivers practical workflows, advanced troubleshooting, and insights from recent research to empower experimental success with APExBIO’s Rotigotine hydrochloride.

15153 records 1/1011 page Next 12345 下5页 Last page